Bajaj Finserv
|

Bajaj Finance Limited

|
Sign In
EMI Card
Notifications
Notifications
Cart
Prime
Partners
  • Fixed Deposit (IFA) Partner Fixed Deposit (IFA) Partner
  • Loan (DSA) Partner Loan (DSA) Partner
  • Debt Management Partner Debt Management Partner
  • EMI Network Partner EMI Network Partner
  • Become a Merchant Become a Merchant
  • Demat and mutual fund partner Demat and mutual fund partner
  • Partners Sign In Partners Sign In
Menu
  • Loans
    • All Loans
    • Personal Loan Apply Online Check Offer
      • Overview Flexi Personal Loan Features and Benefits Eligibility Calculator Fees and Charges How to Apply FAQs Manage your Loans Manage your Flexi Loans Contact Us
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Emergency
    • Insta Personal Loan Check Offer Pre-approved Offer
      • Overview Features Eligibility Calculator Fees and Charges How to Apply Manage your Loans
      • Loans for your Goals

        • Loan for Wedding
        • Loan for Higher Education
        • Loan for Home Renovation
        • Loan for Medical Expenses
    • Business Loan Apply Online Check Offer

        Unsecured

      • MSME World Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Secured

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • Types of Business Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountant Personal Loan for Chartered Accountants
    • Gold Loan Apply Online

        New Loan

      • Overview Features EMI Calculator Eligibility How to Apply Manage your Gold Loan Interest Rate and Charges Gold Rate
      • Balance Transfer

      • Overview Features EMI Calculator Eligibility How to Apply Interest Rate and Charges
    • Loans for Doctors Apply Online Check Offer

        UNSECURED

      • Doctor World Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of Doctor Loans

      • Business Loan for Doctors Personal Loan For Doctors Loan Against Property for Doctors Indemnity Insurance Medical Practice Loan
    • Medical Equipment Finance Apply Online
      • Overview Features Eligibility How to Apply Fees & Charges
    • Loans for CAs Apply Online Check Offer

        UNSECURED

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loans Manage your Flexi Loans
      • SECURED

      • Overview EMI Calculator Features Eligibility How to Apply Fees and charges Manage your loan
      • Types of CA Loans

      • Business Loan for Chartered Accountants Loan Against Property for Chartered Accountants Personal Loan for Chartered Accountants
    • Commercial Lending
      • Overview Term Loans Working Capital Products Corporate Lease Rental Discounting
    • Home Loan Apply Online Check Offer

        Home Loan

      • Home Loan World Overview Features EMI Calculator Eligibility How to Apply Fees and Charges Home Loan Interest Rate
      • Balance Transfer

      • Overview Features Eligibility How to Apply Fees and Charges
      • Categories

      • Home Loan for Doctors Home Loan for Self-employed Home Loan for Salaried
      • Categories

      • Home Loan Balance Transfer for Doctors Home Loan Balance Transfer for Self-employed Home Loan Balance Transfer for Salaried
    • Loan Against Property Apply Online

        LOAN AGAINST PROPERTY

      • Overview Features EMI Calculator Eligibility How to Apply Fees & Charges Loan Against Property Interest Rate
      • BALANCE TRANSFER

      • Overview Features Eligibility How to Apply Fees & Charges
    • Lease Rental Discounting
    • Loan Against Securities Apply Online

        LOAN AGAINST SHARES

      • Overview Features Eligibility How to Apply Fees & Charges Manage your Loan Against Securities FAQ
      • Loan Against Mutual Funds

      • Overview Features Eligibility How to Apply Fees & Charges FAQ
      • Loan Against Bonds

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • Loan Against Insurance Policy

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
      • ESOP Financing

      • Overview Features and Benefits Eligibility How to Apply Fees and Charges FAQs
    • Two-wheeler Loan Apply Online Check Offer
      • Overview Eligibility Features Interest Rates How to Apply Manage your Two-wheeler Loan FAQs
    • New Car Finance Apply Now Check Offer
      • Auto World Overview Features Eligibility How to Apply Interest Rates and Charges FAQs Manage your loan Manage your flexi loan
    • Used Car Loan Apply Now Check Offer

        Used Car Finance

      • Auto World Explore Used Cars and Loan Overview Features and benefits Eligibility EMI Calculator Used Car Loan Eligibility Calculator Fees and charges How to Apply FAQs Manage your loan Manage your flexi loan
      • Categories

      • Loan against car Car loan balance transfer
    • Loan Against Car Apply Now Check Offer

        Loan Against Car

      • Auto World Overview Features and benefits Eligibility EMI Calculator Loan Against Car Eligibility Calculator Fees and charges How to Apply FAQS Manage your loan Manage your flexi loan
      • Categories

      • Used car loan Car loan balance transfer
    • Car Loan Balance Transfer and Top-up Apply Now Check Offer

        Balance Transfer

      • Auto World Overview Features and benefits Eligibility EMI Calculator Car Loan Balance Transfer and Top Up Eligibility Calculator Fees and Charges How to Apply Manage your loan FAQS Manage your flexi loan
      • Categories

      • Used car loan Loan against car
    • Microfinance Group Loan
    • Tractor Loan
    • Loan for Lawyer
    • Easy EMI Loan
  • All on EMI
    • Electronics
    • Two-wheelers
    • Lifestyle
    • Travel
      • Our Partner Make My Trip Goibibo IRCTC
    • Shop on Ecommerce
      • Our Partner Flipkart Amazon
    • Offers & Promotions
    • Tractor
  • Bajaj Mall
    • Smartphones
    • Washing Machines
    • LED TVs
    • Refrigerators
    • Air Conditioners
    • Water Purifiers
    • Two-wheelers
    • Smartwatches
    • Laptops
    • Mattresses
    • Furniture
    • Kitchen Appliances
    • Cycles
    • Fitness Equipment
    • Air Cooler
    • Watches
    • Audio Devices
    • Camera Accessories
  • Card
    • Insta EMI Card Apply Online
      • Overview Features and Benefits Eligibility Fees and Charges How to Apply Manage your Insta EMI Card Contact Us
  • Investments
    • All Investments
    • Fixed Deposit Open FD
      • Overview FD Calculator Features and Benefits FD Interest Rates Eligibility and Documents How to Invest FAQs Manage your FD Contact Us
      • FIXED DEPOSIT FOR YOUR GOALS

        • Fixed Deposit for Retirement Fund
        • Fixed Deposit for Higher Education
        • Fixed Deposit for Home Expenses
        • Fixed Deposit for Wedding Expenses
    • Mutual Funds Open MF Account Explore Funds

        About the Product

      • SIP Calculator Overview Explore All MFs How to Invest FAQs Contact Us
      • Fund Category

      • Debt Funds Equity Funds Hybrid Funds ELSS Funds Thematic Funds Multi Cap Fund NFO Large Cap Mutual Funds Mid Cap Mutual Funds Small Cap Mutual Funds Liquid Mutual Funds Aggressive Hybrid Mutual Funds
      • Funds by Returns

      • 1 Month Returns 3 Months Returns 1 Year Returns 3 Years Returns Max Returns
      • Quick Links

      • Portfolio Order in progress Open mutual fund account Dashboard New Fund Offer (NFO)
    • Stock Trading Open A/C
      • Start Trading Open Demat Account Overview FAQ Contact Us
    • Partner Portal
    • Become Our Partner
  • Insurance
    • Insurance Mall
    • Health Insurance Explore Plans

        Health Insurance

      • Overview Get Quote FAQs
      • Family Health Insurance

      • Aditya Birla Group Activ Health Plan (ABCD) Bajaj Allianz Health Guard Insurance Plan ManipalCigna Pro-Health Group Niva Bupa Health Plus Plan Aditya Birla Active Assure Diamond
      • Top-up Health Insurance

      • Group Activ Health Super Top-Up Bajaj Allianz Extra care plus plan
      • Partners

      • Aditya Birla Health Insurance Bajaj Allianz General Insurance Niva Bupa Health Insurance Bajaj Finserv Health ManipalCigna Health Insurance
    • Car Insurance Explore Plans

        Car Insurance

      • Overview Get Quote FAQs
      • Partners

      • ACKO General Insurance Bajaj Allianz General Insurance SBI General Insurance
      • Comprehensive Car Insurance

      • ACKO Car Insurance Bajaj Allianz Car Insurance SBI General Car Insurance
      • Own Damage

      • Bajaj Allianz Car Insurance SBI General Car Insurance
    • Pocket Insurance Explore Plans

        Best Seller

      • Personal Accident Cover Group Activ Health Super top up Cover
      • Under 699

      • Cancer Secure Gym Injury Insurance Pregnancy Complications Cover Baggage Insurance
      • Health Must Have

      • Niva Bupa Health Plus Dental Cover Sports/Fitness Injury Fracture Cover Health Plus Hospital Cash
      • Monsoon Insurance

      • Dengue & Malaria Cover Monsoon Insurance Viral Fever(Infection) CPP Liv Protect Group Activ Secure Policy- Personal Accident Cover 18-55 Years
    • Investment Plans Explore Plans

        Investment Plans

      • Overview
      • Partners

      • HDFC Life Bajaj Allianz Life Insurance
      • Guaranteed Savings

      • HDFC Life Guaranteed Savings Plan Bajaj Allianz Life POS Goal Suraksha Plan
    • Life Insurance Explore Plans

        Life Insurance

      • Overview Get Quote
      • Partner

      • Bajaj Allianz Life Insurance HDFC Life insurance Future Generali India Life Insurance
    • Professional Indemnity Explore Now

        Professional Indemnity

      • Overview Get Quote Bajaj Allianz Professional Indemnity Insurance Plan View All
      • Partners

      • Bajaj Allianz General Insurance
    • Manage your Insurance
  • Payments
    • All Payments
    • Mobile Recharge Pay Now
      • Jio Airtel Vi BSNL
    • Electricity Bill Payment Pay Now
      • Maharashtra State Electricity Distbn Co Ltd West Bengal Electricity Torrent Power Tamil Nadu Electricity Board (TNEB) Central Power Distribution Corporation Ltd. of Andhra Pradesh (APCPDCL) Calcutta Electric Supply Corporation (CESC) Jaipur Vidyut Vitran Nigam (JVVNL) APEPDCL-Eastern Power Distribution CO AP Ltd South Bihar Power Distribution Company Ltd. Southern Power Distribution Co Ltd of Andhra Pradesh Purvanchal Vidyut Vitaran Nigam Limited
    • Gas Booking Pay Now
      • Indane Gas (Indian Oil) Bharat Gas (BPCL) HP Gas (HPCL)
    • Loan Repayment Pay Now
      • Bajaj Finance Limited Agent Collection DMI Finance Private Limited Annapurna Finance Private Limited-MFI Bajaj Auto Finance Ujjivan Small Finance Bank TVS Credit IIFL Finance Limited
    • FASTag Buy New Recharge
      • IDFC FIRST Bank - FASTag Airtel Payments Bank NETC FASTag ICICI Bank FASTag HDFC  Bank - FASTag State Bank of India - NETC FASTag Kotak Mahindra Bank - FASTag Axis Bank FASTag IndusInd Bank FASTag
    • DTH Pay Now
      • Dish TV Videocon D2H Airtel DTH Tata Sky Sun Direct TV
    • Credit Card Bill payment Pay Now
      • SBI Card RBL Bank Credit Card HDFC Bank Credit Card ICICI Bank Credit Card Axis Bank Credit Card DBS Credit Card BoB Credit Card IDFC FIRST Bank Credit Card Yes Bank Credit Card Kotak Mahindra Bank Credit Card AU Bank Credit Card
    • Bajaj Pay Wallet
    • Bajaj Pay Gift Card Buy Now
      • My Cards Gift Card Categories
    • Rewards
      • Rewards & Offers Flipkart Gift Card Redbus Gift Card Swiggy Gift Card Amazon Gift Card Zomato Gift Card
  • Offers
    • All Offers
    • Loans
    • Electronics and Appliances
    • Personal Loan
    • EMI Card
    • Investment
    • Business Loan
    • Lifestyle
    • Home Loan
    • Insurance
    • Doctor Loan
    • Two wheeler
    • CA Loan
    • Used Cars
    • Loan Against Securities
    • Broking
    • Rewards
    • Gold Loan
    • Payments
  • Services
    • Locate Us
      • Branches EMI Network Partner Stores Hospitals & Wellness Centres Insurance Network Hospitals Collection Centres
    • All Service Guides
    • Raise a Request
      • Overview Raise a Request Follow-up on an open request Re-open a closed request
    • Manage your Profile
      • Overview Contact Details Personal Details GST Details
    • Manage your Mandate
      • Overview Register Mandate Change Mandate
    • Repay your Loans
      • Overview Clear Overdue EMIs Pay Advance EMIs Part-prepay your Loans Foreclose your Loans Manage your loan settlement
    • Manage your Loans
      • Overview Consumer Durable Loans Flexi Loans Loan Against Fixed Deposit Loan Against Securities Gold Loan Two-wheeler Loan
    • Manage your Cards
      • Insta EMI card Health EMI Network Card
    • Manage your Investments
      • Fixed Deposit Systematic Deposit Plan
    • Manage your Insurance
      • Overview Policy Details Renew your Policy Claim your Policy Cancel your Policy Surrender your Policy
  • About Bajaj Finserv
    • Investor Relations
    • People and Committees
    • About Us
    • Impact
    • TICC
    • Careers
  • pay emi image Pay EMI
  • Do not call image Do not call
  • Download the app image Download the app
Sign In

Main Menu

  • Food & Grocery
    Main Menu
    Food & Grocery
    • Food & Beverages
    • Grocery
    • Fashion
    • Beauty & Personal Care
    • Health & Wellness
    • Home & Kitchen
  • Bajaj Pay
    Main Menu
    Bajaj Pay
    • Bajaj Pay
    • Wallet
    • Refer & Earn
    • Mobile Recharge
    • Buy FASTag
    • Bill Payments & Other Recharges
    • Add Money
  • Loans
    Main Menu
    Loans
    • Personal Loan
    • Gold Loan
    • Business Loan
    • Loan for Doctors
    • Home Loan
    • Secured Business Loan
    • Loan Against Property
    • Loan Against Shares
    • Loan for Chartered Accountants
    • Medical Equipment Finance
    • Loan Against Property Balance Transfer
    • Home Loan Balance Transfer
    • Loan Against Mutual Funds
    • Loan Against Bonds
    • Loan Against Insurance Policy
    • ESOP Financing
    • Two-wheeler Loan
    • Buy a Used Car
    • Tractor Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • New Car Loan
    • Loan for Lawyer
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
    • Easy EMI Loan
  • Electronics & Smartphones
    Main Menu
    Electronics & Smartphones
    • Smartphones
    • Air Conditioner
    • Led TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Easy EMI Loan
  • EMI Card
    Main Menu
    EMI Card
    • Insta EMI Card
  • Share Market
    Main Menu
    Share Market
    • Trading Account
    • Open Demat Account
    • Margin Trading Financing
    • Share Market
    • Invest in IPO
    • All stocks
    • Top gainers
    • Top losers
    • 52 week high
    • 52 week low
    • Loan against shares
  • MSME World
    Main Menu
    MSME World
    • Business Loan
    • Secured Business Loan
    • Loan against property
    • Loans against property balance transfer
    • Loan against shares
    • Home Loan
    • Loans against mutual funds
    • Loan against bonds
    • Loan against insurance policy
    • Industrial Equipment Finance
    • Industrial Equipment Balance Transfer
    • Industrial Equipment Refinance
  • Insurance
    Main Menu
    Insurance
    • Health Insurance
    • Term Life Insurance
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Investment Plans
    • Wallet Care
    • Waller Care Entertainment +
    • Personal Accident Care
    • EMI/SIP Cover
    • Health Prime Max
    • Fonesafe Lite
    • Mobile Protect
    • Wallet Protekt
    • Dengue Cover
    • Niva Bupa Health Plus
    • Health Plus Hospital Cash
    • Four Wheeler Insurance
  • Bajaj Prime
    Main Menu
    Bajaj Prime
    • Get Bajaj Prime
  • Investments
    Main Menu
    Investments
    • Fixed Deposit
    • Renew Fixed Deposit
    • ULIP Plan
    • Savings Plan
    • Retirement Plans
    • Child Plans
    • Free Demat Account
    • Invest in Stocks
    • Invest in IPO
    • Margin Trading Facility
    • Equity Mutual Funds
    • Debt Mutual Funds
    • Hybrid Mutual Funds
    • New Fund Offers
    • Open Mutual Fund Account
  • Gold Loan
    Main Menu
    Gold Loan
    • Apply for Gold Loan
    • Transfer your Gold Loan with Us
  • Two Wheeler World
    Main Menu
    Two Wheeler World
    • Bike
    • Scooter
    • Electric Vehicle
    • Best Sellers
    • Popular Brands
  • Credit Score
    Main Menu
    Credit Score
    • Check your Credit Score
  • Fun Zone
    Main Menu
    Fun Zone
    • Engagement Zone
    • Game Zone
  • Auto World
    Main Menu
    Auto World
    • New Car Loan
    • Used Car Loan
    • Loan Against Car
    • Car Loan Balance Transfer and Top-up
    • Buy a Used Car
  • Easy EMI Loan
    Main Menu
    Easy EMI Loan
    • Mobiles and Electronics on Easy EMI
  • Calculators
    Main Menu
    Calculators
    • Personal Loan EMI Calculator
    • Personal Loan Eligibility Calculator
    • Home Loan EMI Calculator
    • Home Loan Eligibility Calculator
    • Good & Service Tax (GST) Calculator
    • Flexi Day Wise Interest Calculator
    • Flexi Transaction Calculator
    • Secured Business Loan Eligibility Calculator
    • Fixed Deposits Interest Calculator
    • Two wheeler Loan EMI Calculator
    • New Car Loan EMI Calculator
    • Used Car Loan EMI Calculator
    • All Calculator
  • Lifestyle
    Main Menu
    Lifestyle
    • Hot Deals
    • Clearance Sale
    • Kitchen Appliances
    • Tyres
    • Camera & Accessories
    • Mattresses
    • Furniture
    • Watches
    • Music & Audio
    • Cycles
    • Mixer & Grinder
    • Luggage & Travel
    • Fitness Equipment
    • Fans
  • Doctor World
    Main Menu
    Doctor World
    • Personal Loan for Doctors
    • Business loan for Doctors
    • Medical Equipment Finance
    • Secured Business Loan
    • Loan against property
    • Loan against share
    • Gold Loan
    • Home Loan
  • All on EMI
    Main Menu
    All on EMI
    • Smartphones
    • Air Conditioners
    • LED TVs
    • Air Coolers
    • Refrigerators
    • Washing Machines
    • Laptops
    • Water Purifiers
    • Tablets
    • Kitchen Appliances
    • Mattresses
    • Furniture
    • Music and Audio
    • Cameras & Accessories
    • Cycle
    • Watches
    • Tyres
    • Luggage & Travel
    • Fitness Equipment
    • Tractor
    • Easy EMI Loan
  • Home Loan World
    Main Menu
    Home Loan World
    • Home Loan
    • Transfer your existing Home loan
    • Loan against Property
    • Home Loan for Salaried
    • Home loan for self employed
    • Home Loan EMI Calculator
    • Home Loan eligibility calculator
    • Home Loan balance transfer
  • Deals and Savings
    Main Menu
    Deals and Savings
    • Easy EMI
    • Offer World
    • 1 EMI OFF
    • New Launches
    • Zero Down Payment
    • Clearance Sale
    • Bajaj Mall Sale
  • Articles
    Main Menu
    Articles
    • Articles
  • Loan Payments
    Main Menu
    Loan Payments
    • Overdue Payments
    • Other Payments
  • Bank details/ Documents
    Main Menu
    Bank details/ Documents
    • Document Center
    • Bank details & Documents
    • Tax Invoice Certificate
  • Do Not Call Service
    Main Menu
    Do Not Call Service
    • Do Not Call Service
  • Your Things
    Main Menu
    Your Things
    • Your Orders
    • Hamara Mall Orders
  • Rewards
    Main Menu
    Rewards
    • Explore Bajaj Prime
    • Explore Rewards
    • Buy Deals & Gift cards
  • Partners
    Main Menu
    Partners
    • Fixed Deposit (IFA) Partner
    • Loan (DSA) Partner
    • Debt Management Partner
    • EMI Network Partner
    • Become a Merchant
    • Partner Sign-in
  • What's New
    Main Menu
    What's New
    • Food & Shopping
    • Credit Card Hub
    • ULIP Plans
    • Top Gainers Stock
    • Top Losers Stock
    • Saving Plan
    • Term Insurance
    • Easy EMI Loan
  • Watch Live
    Main Menu
    Watch Live
    • Live Videos
  • Help and Support
  • Settings
    Main Menu
    Settings
    • Update Profile
    • Manage Consent
    • Refer and Earn
    • About Us
    • Important Information
    • Terms of Service
    • Privacy Policy
    • Fair Practice Code
    • Citizen Charter
    • LogOut
    • TICC
  • Home
  • Account
  • More
  • Pay EMIs
  • Menu
Menu
Food & Grocery

Food & Grocery

  • Food & BeveragesFood & Beverages
  • GroceryGrocery
  • FashionFashion
  • Beauty & Personal CareBeauty & Personal Care
  • Health & WellnessHealth & Wellness
  • Home & KitchenHome & Kitchen
Bajaj Pay

Bajaj Pay

  • Bajaj PayBajaj Pay
  • WalletWallet
  • Refer & EarnRefer & Earn
  • Mobile RechargeMobile Recharge
  • Buy FASTagBuy FASTag
  • Bill Payments & Other RechargesBill Payments & Other Recharges
  • Add MoneyAdd Money
Loans

Loans

  • Personal LoanPersonal Loan
  • Gold LoanGold Loan
  • Business LoanBusiness Loan
  • Loan for DoctorsLoan for Doctors
  • Home LoanHome Loan
  • Secured Business LoanSecured Business Loan
  • Loan Against PropertyLoan Against Property
  • Loan Against SharesLoan Against Shares
  • Loan for Chartered AccountantsLoan for Chartered Accountants
  • Medical Equipment FinanceMedical Equipment Finance
  • Loan Against Property Balance TransferLoan Against Property Balance Transfer
  • Home Loan Balance TransferHome Loan Balance Transfer
  • Loan Against Mutual FundsLoan Against Mutual Funds
  • Loan Against BondsLoan Against Bonds
  • Loan Against Insurance PolicyLoan Against Insurance Policy
  • ESOP FinancingESOP Financing
  • Two-wheeler LoanTwo-wheeler Loan
  • Buy a Used CarBuy a Used Car
  • Tractor LoanTractor Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • New Car LoanNew Car Loan
  • Loan for LawyerLoan for Lawyer
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
  • Easy EMI LoanEasy EMI Loan
Electronics & Smartphones

Electronics & Smartphones

  • SmartphonesSmartphones
  • Air ConditionerAir Conditioner
  • Led TVsLed TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Easy EMI LoanEasy EMI Loan
EMI Card

EMI Card

  • Insta EMI CardInsta EMI Card
Share Market

Share Market

  • Trading AccountTrading Account
  • Open Demat AccountOpen Demat Account
  • Margin Trading FinancingMargin Trading Financing
  • Share MarketShare Market
  • Invest in IPOInvest in IPO
  • All stocksAll stocks
  • Top gainersTop gainers
  • Top losersTop losers
  • 52 week high52 week high
  • 52 week low52 week low
  • Loan against sharesLoan against shares
msme-world

MSME World

  • Business LoanBusiness Loan
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loans against property balance transferLoans against property balance transfer
  • Loan against sharesLoan against shares
  • Home LoanHome Loan
  • Loans against mutual fundsLoans against mutual funds
  • Loan against bondsLoan against bonds
  • Loan against insurance policyLoan against insurance policy
  • Industrial Equipment FinanceIndustrial Equipment Finance
  • Industrial Equipment Balance TransferIndustrial Equipment Balance Transfer
  • Industrial Equipment RefinanceIndustrial Equipment Refinance
Insurance

Insurance

  • Health InsuranceHealth Insurance
  • Term Life InsuranceTerm Life Insurance
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Investment PlansInvestment Plans
  • Wallet CareWallet Care
  • Waller Care Entertainment +Waller Care Entertainment +
  • Personal Accident CarePersonal Accident Care
  • EMI/SIP CoverEMI/SIP Cover
  • Health Prime MaxHealth Prime Max
  • Fonesafe LiteFonesafe Lite
  • Mobile ProtectMobile Protect
  • Wallet ProtektWallet Protekt
  • Dengue CoverDengue Cover
  • Niva Bupa Health PlusNiva Bupa Health Plus
  • Health Plus Hospital CashHealth Plus Hospital Cash
  • Four Wheeler InsuranceFour Wheeler Insurance
Bajaj Prime

Bajaj Prime

  • Get Bajaj PrimeGet Bajaj Prime
Investments

Investments

  • Fixed DepositFixed Deposit
  • Renew Fixed DepositRenew Fixed Deposit
  • ULIP PlanULIP Plan
  • Savings PlanSavings Plan
  • Retirement PlansRetirement Plans
  • Child PlansChild Plans
  • Free Demat AccountFree Demat Account
  • Invest in StocksInvest in Stocks
  • Invest in IPOInvest in IPO
  • Margin Trading FacilityMargin Trading Facility
  • Equity Mutual FundsEquity Mutual Funds
  • Debt Mutual FundsDebt Mutual Funds
  • Hybrid Mutual FundsHybrid Mutual Funds
  • New Fund OffersNew Fund Offers
  • Open Mutual Fund AccountOpen Mutual Fund Account
Gold Loan

Gold Loan

  • Apply for Gold LoanApply for Gold Loan
  • Transfer your Gold Loan with UsTransfer your Gold Loan with Us
Two Wheeler World

Two Wheeler World

  • BikeBike
  • ScooterScooter
  • Electric VehicleElectric Vehicle
  • Best SellersBest Sellers
  • Popular BrandsPopular Brands
Credit Score

Credit Score

  • Check your Credit ScoreCheck your Credit Score
Fun Zone

Fun Zone

  • Engagement ZoneEngagement Zone
  • Game ZoneGame Zone
Auto World

Auto World

  • New Car LoanNew Car Loan
  • Used Car LoanUsed Car Loan
  • Loan Against CarLoan Against Car
  • Car Loan Balance Transfer and Top-upCar Loan Balance Transfer and Top-up
  • Buy a Used CarBuy a Used Car
Easy EMI Loan

Easy EMI Loan

  • Mobiles and Electronics on Easy EMIMobiles and Electronics on Easy EMI
Calculators

Calculators

  • Personal Loan EMI CalculatorPersonal Loan EMI Calculator
  • Personal Loan Eligibility CalculatorPersonal Loan Eligibility Calculator
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan Eligibility CalculatorHome Loan Eligibility Calculator
  • Good & Service Tax (GST) CalculatorGood & Service Tax (GST) Calculator
  • Flexi Day Wise Interest CalculatorFlexi Day Wise Interest Calculator
  • Flexi Transaction CalculatorFlexi Transaction Calculator
  • Secured Business Loan Eligibility CalculatorSecured Business Loan Eligibility Calculator
  • Fixed Deposits Interest CalculatorFixed Deposits Interest Calculator
  • Two wheeler Loan EMI CalculatorTwo wheeler Loan EMI Calculator
  • New Car Loan EMI CalculatorNew Car Loan EMI Calculator
  • Used Car Loan EMI CalculatorUsed Car Loan EMI Calculator
  • All CalculatorAll Calculator
Lifestyle

Lifestyle

  • Hot DealsHot Deals
  • Clearance SaleClearance Sale
  • Kitchen AppliancesKitchen Appliances
  • TyresTyres
  • Camera & AccessoriesCamera & Accessories
  • MattressesMattresses
  • FurnitureFurniture
  • WatchesWatches
  • Music & AudioMusic & Audio
  • CyclesCycles
  • Mixer & GrinderMixer & Grinder
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • FansFans
Doctor World

Doctor World

  • Personal Loan for DoctorsPersonal Loan for Doctors
  • Business loan for DoctorsBusiness loan for Doctors
  • Medical Equipment FinanceMedical Equipment Finance
  • Secured Business LoanSecured Business Loan
  • Loan against propertyLoan against property
  • Loan against shareLoan against share
  • Gold LoanGold Loan
  • Home LoanHome Loan
All on EMI

All on EMI

  • SmartphonesSmartphones
  • Air ConditionersAir Conditioners
  • LED TVsLED TVs
  • Air CoolersAir Coolers
  • RefrigeratorsRefrigerators
  • Washing MachinesWashing Machines
  • LaptopsLaptops
  • Water PurifiersWater Purifiers
  • TabletsTablets
  • Kitchen AppliancesKitchen Appliances
  • MattressesMattresses
  • FurnitureFurniture
  • Music and AudioMusic and Audio
  • Cameras & AccessoriesCameras & Accessories
  • CycleCycle
  • WatchesWatches
  • TyresTyres
  • Luggage & TravelLuggage & Travel
  • Fitness EquipmentFitness Equipment
  • TractorTractor
  • Easy EMI LoanEasy EMI Loan
Home Loan World

Home Loan World

  • Home LoanHome Loan
  • Transfer your existing Home loanTransfer your existing Home loan
  • Loan against PropertyLoan against Property
  • Home Loan for SalariedHome Loan for Salaried
  • Home loan for self employedHome loan for self employed
  • Home Loan EMI CalculatorHome Loan EMI Calculator
  • Home Loan eligibility calculatorHome Loan eligibility calculator
  • Home Loan balance transferHome Loan balance transfer
Deals and Savings

Deals and Savings

  •  Easy EMI Easy EMI
  • Offer WorldOffer World
  • 1 EMI OFF1 EMI OFF
  • New LaunchesNew Launches
  • Zero Down PaymentZero Down Payment
  • Clearance SaleClearance Sale
  • Bajaj Mall SaleBajaj Mall Sale
Articles

Articles

  • ArticlesArticles
Loan Payments

Loan Payments

  • Overdue PaymentsOverdue Payments
  • Other PaymentsOther Payments
Bank details/ Documents

Bank details/ Documents

  • Document CenterDocument Center
  • Bank details & DocumentsBank details & Documents
  • Tax Invoice CertificateTax Invoice Certificate
Do Not Call Service

Do Not Call Service

  • Do Not Call ServiceDo Not Call Service
Your Things

Your Things

  • Your OrdersYour Orders
  • Hamara Mall OrdersHamara Mall Orders
Rewards

Rewards

  • Explore Bajaj PrimeExplore Bajaj Prime
  • Explore RewardsExplore Rewards
  • Buy Deals & Gift cardsBuy Deals & Gift cards
Partners

Partners

  • Fixed Deposit (IFA) PartnerFixed Deposit (IFA) Partner
  • Loan (DSA) PartnerLoan (DSA) Partner
  • Debt Management PartnerDebt Management Partner
  • EMI Network PartnerEMI Network Partner
  • Become a MerchantBecome a Merchant
  • Partner Sign-inPartner Sign-in
What's New

What's New

  •  Food & Shopping Food & Shopping
  • Credit Card HubCredit Card Hub
  • ULIP PlansULIP Plans
  • Top Gainers StockTop Gainers Stock
  • Top Losers StockTop Losers Stock
  • Saving PlanSaving Plan
  • Term InsuranceTerm Insurance
  • Easy EMI LoanEasy EMI Loan
Watch Live

Watch Live

  • Live VideosLive Videos
Help and Support
Settings
Update Profile Manage Consent Refer and Earn About Us Important Information Terms of Service Privacy Policy Fair Practice Code Citizen Charter LogOut TICC
Relations Documents Profile Loan Payments

Error

400

We are sorry.

There's nothing here yet.

BACK TO HOMEPAGE
  • Overview
  • Performance
  • Fundamentals
  • Financials
  • Technical summary
  • Shareholding pattern
  • About
  • View more stocks
  • All stocks
  • Top gainers
  • Top losers
  • FAQs

ZYDUS LIFESCIENCES LTD

ZYDUSLIFE

NSE

BSE

Pharmaceuticals

₹ 904.0

14.34 1.61%

OPEN DEMAT ACCOUNT

Stock price as on May 22 2025 03:29 PM

Stock performance

Performance

Company fundamentals

Fundamentals

Company financials

Financials

Stock technical summary

Technical summary

Company shareholding pattern

Shareholding pattern

About

About {Company_Name}

Similar stocks

Similar stocks

FAQs

FAQs

Performance Graph
YTD 1 Week 1 Months 3 Months 6 Months 1 Year 1.61% -1.53% 5.24% 0.48% -5.76% -18.25%

Zydus Lifesciences Ltd stock performance

Today’s low

889.35

Today’s high

911.5

904.0

52 week low

795.0

52 week high

1324.3

908.5

Open

890.0

Previous close

889.65

Share volume

1459818.0

Total traded value (Lakh)

13262.44

Upper circuit

978.6

Lower circuit

800.7

Stock performance

This data indicates the stock's performance over a specific period, measured by tracking its price movements.

<p><b>Open</b></p> <p style="text-align: left;">The price at which a stock begins trading at the start of the trading day.<br /> </p> <p> </p> <p><b>Previous close</b></p> <p style="text-align: left;">The price at which a stock ended trading on the previous day.<br /> </p> <p> </p> <p><b>Share volume</b></p> <p style="text-align: left;">The total number of shares  traded during a specific period, typically within a trading day.</p> <p> </p> <p><b>Trade value</b></p> <p>The total value of all trades made during a specific period.<br /> </p> <p> </p> <p><b>Upper circuit</b></p> <p>The maximum allowed price increase in a stock during a single session, after which trading is temporarily paused.</p> <p> </p> <p><b>Lower circuit</b></p> <p>The maximum allowed price decrease in a stock during a single session, after which trading is temporarily paused.</p> <p> </p>

Zydus Lifesciences Ltd fundamentals

Market cap (Cr)
90963.55
P/E ratio (TTM)
15.5
Book value per share
₹ 0.0
Beta
0.75
Return on equity
23.45
Earnings per share (TTM)
₹ 57.39
Dividend yield
1.24%
Net profit/quarter (Cr)
₹ 2813.7

Fundamentals

Understand the common terms associated with a company's stock fundamentals

<p><b>Market cap</b></p> <p>The total value of a company's outstanding shares, calculated by multiplying the current stock price with the number of shares.<br> </p> <p>&nbsp;</p> <p><b>P/E ratio (TTM)</b></p> <p style="text-align: left;">The price-to-earnings ratio, showing how investors value a company by dividing the stock price by earnings per share (EPS).<br> </p> <p>&nbsp;</p> <p><b>Book value per share</b></p> <p style="text-align: left;">The value of a company per share, calculated by dividing the company's net assets by the total number of shares.</p> <p style="text-align: left;">&nbsp;</p> <p><b>Beta</b></p> <p>A measure of a stock’s volatility compared to the&nbsp; market:</p> <p>&nbsp;</p> <p>Beta of 1: Stock moves with the market.</p> <p>Beta &gt; 1: More volatile.</p> <p>Beta &lt; 1: Less volatile.</p> <p>&nbsp;</p> <p><b>Return on equity</b></p> <p style="text-align: left;">Indicates how profitable a company is compared to shareholder investment, calculated by dividing net income by shareholders' equity.<br> </p> <p>&nbsp;</p> <p><b>Earnings per share (TTM)</b></p> <p>The profit earned per share over the past 12 months.<br> </p> <p>&nbsp;</p> <p><b>Dividend yield</b></p> <p>The return on investment from dividends, calculated by dividing the annual dividend by the current share price.</p> <p>&nbsp;</p> <p><b>Net profit/quarter</b></p> <p>The profit a company makes in a quarter after all expenses and taxes are deducted.</p> <p>&nbsp;</p>

Zydus Lifesciences Ltd financials

(Values in Cr)

Revenue

Net income

Revenue

Particulars

202503 (₹ value in crores)

Revenue

5633.5

Operating expense

2330.3

Net income

2813.7

Net profit margin

49.94%

Earnings per share

27.96

EBITDA

3958.1

Effective tax rate

23.43
Revenue

Particulars

202412 (₹ value in crores)

Revenue

2408.9

Operating expense

2096.2

Net income

470.6

Net profit margin

19.53%

Earnings per share

4.68

EBITDA

726.0

Effective tax rate

5.34
Revenue

Particulars

202409 (₹ value in crores)

Revenue

2512.3

Operating expense

1908.0

Net income

789.8

Net profit margin

31.43%

Earnings per share

7.85

EBITDA

1268.9

Effective tax rate

24.0
Revenue

Particulars

202406 (₹ value in crores)

Revenue

4035.4

Operating expense

2033.3

Net income

1700.8

Net profit margin

42.14%

Earnings per share

16.9

EBITDA

2479.5

Effective tax rate

23.85
Revenue

Particulars

202403 (₹ value in crores)

Revenue

3172.6

Operating expense

2000.0

Net income

1405.2

Net profit margin

44.29%

Earnings per share

13.89

EBITDA

1921.7

Effective tax rate

16.6

(Values in Cr)

Revenue

Net income

Revenue Annual

Particulars

202503 (₹ value in crores)

Revenue

14590.1

Operating expense

8367.8

Net income

5774.9

Net profit margin

39.58%

Earnings per share

57.39

EBITDA

8432.5

Effective tax rate

22.42
Revenue Annual

Particulars

202403 (₹ value in crores)

Revenue

10317.6

Operating expense

7655.09

Net income

3441.5

Net profit margin

33.35%

Earnings per share

34.01

EBITDA

5134.9

Effective tax rate

18.82
Revenue Annual

Particulars

202303 (₹ value in crores)

Revenue

8421.2

Operating expense

7044.0

Net income

1529.2

Net profit margin

18.15%

Earnings per share

15.06

EBITDA

2799.0

Effective tax rate

24.75
Revenue Annual

Particulars

202203 (₹ value in crores)

Revenue

7590.0

Operating expense

6532.4

Net income

857.9

Net profit margin

11.3%

Earnings per share

8.38

EBITDA

1777.5

Effective tax rate

26.29
Revenue Annual

Particulars

202103 (₹ value in crores)

Revenue

7436.7

Operating expense

5993.29

Net income

1476.2

Net profit margin

19.85%

Earnings per share

14.42

EBITDA

2210.5

Effective tax rate

12.57

Financials

<p><b>Quarterly</b>: Months listed along the bottom of the graph represent a quarter.</p> <p><b>Annual</b>: Months listed along the bottom of the graph represent a financial year.<br /> </p>

ROE

ROCE

Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

197.11

Return on Equity (ROE)

20.64

Return on Capital Employed (ROCE)

23.94

Total debt to equity ratio

0.05

EBITDA margin

29.04
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

173.08

Return on Equity (ROE)

14.05

Return on Capital Employed (ROCE)

16.25

Total debt to equity ratio

0.16

EBITDA margin

23.35
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

166.01

Return on Equity (ROE)

29.82

Return on Capital Employed (ROCE)

14.43

Total debt to equity ratio

0.29

EBITDA margin

23.61
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

126.88

Return on Equity (ROE)

20.32

Return on Capital Employed (ROCE)

15.12

Total debt to equity ratio

0.54

EBITDA margin

23.86
Consolidated Ratios

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

101.33

Return on Equity (ROE)

14.18

Return on Capital Employed (ROCE)

11.91

Total debt to equity ratio

0.77

EBITDA margin

20.43

ROE

ROCE

Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

156.23

Return on Equity (ROE)

23.45

Return on Capital Employed (ROCE)

22.73

Total debt to equity ratio

0.37

EBITDA margin

47.46
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

134.78

Return on Equity (ROE)

11.38

Return on Capital Employed (ROCE)

13.31

Total debt to equity ratio

0.28

EBITDA margin

32.06
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

129.3

Return on Equity (ROE)

8.43

Return on Capital Employed (ROCE)

9.84

Total debt to equity ratio

0.25

EBITDA margin

26.8
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

124.46

Return on Equity (ROE)

13.61

Return on Capital Employed (ROCE)

12.22

Total debt to equity ratio

0.32

EBITDA margin

30.87
Satandalone Data

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

109.96

Return on Equity (ROE)

14.25

Return on Capital Employed (ROCE)

13.53

Total debt to equity ratio

0.37

EBITDA margin

35.92

Financials

<p>Months listed along the bottom of the graph represent a financial year.<br /> </p> <p>         </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of the single company.<br /> </p>

(Values in Cr)

Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1105.1

29280.8

29280.8

Total Equity

22101.6

Shares Outstanding

1006233990

Price to book ratio

6.43

Return on assets (%)

13.18

Return on capital (%)

16.88
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

573.1

25756.4

25756.4

Total Equity

19688.3

Shares Outstanding

1012204139

Price to book ratio

3.65

Return on assets (%)

7.61

Return on capital (%)

9.4
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

1106.9

27795.4

27795.4

Total Equity

19053.8

Shares Outstanding

1023742600

Price to book ratio

2.7

Return on assets (%)

16.14

Return on capital (%)

19.3
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

888.3

23884.7

23884.7

Total Equity

14929.6

Shares Outstanding

1023742600

Price to book ratio

3.54

Return on assets (%)

8.93

Return on capital (%)

10.93
Consolidated Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

964.9

23686.6

23686.6

Total Equity

11710.4

Shares Outstanding

1023742600

Price to book ratio

2.43

Return on assets (%)

4.96

Return on capital (%)

6.27

(Values in Cr)

Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

414.4

24084.8

24084.8

Total Equity

15716.5

Shares Outstanding

1006233990

Price to book ratio

6.43

Return on assets (%)

14.28

Return on capital (%)

15.72
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

248.1

20563.6

20563.6

Total Equity

13639.4

Shares Outstanding

1012204139

Price to book ratio

3.65

Return on assets (%)

7.43

Return on capital (%)

8.28
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

302.6

17740.0

17740.0

Total Equity

13240.5

Shares Outstanding

1023742600

Price to book ratio

2.7

Return on assets (%)

4.83

Return on capital (%)

5.39
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

154.0

18463.6

18463.6

Total Equity

12744.5

Shares Outstanding

1023742600

Price to book ratio

3.54

Return on assets (%)

7.99

Return on capital (%)

8.86
Standalone Balance Sheet

Particulars

Mar 24 (₹ value in crores)

Cash and short-term investments

385.3

16551.5

16551.5

Total Equity

11260.2

Shares Outstanding

1023742600

Price to book ratio

2.43

Return on assets (%)

8.53

Return on capital (%)

9.94

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

(Values in Cr)

Net income

Net change

Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

4838.1

Cash from operations

4513.7

Cash from investing

-1475.2

Cash from financing

-1810.4

Net change in cash

-57.7

Free cash flow

5420.3
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

2582.7

Cash from operations

3280.8

Cash from investing

1535.0

Cash from financing

-4400.4

Net change in cash

-176.6

Free cash flow

4311.7
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

5232.3

Cash from operations

2779.1

Cash from investing

-1000.3

Cash from financing

-868.3

Net change in cash

235.9

Free cash flow

3981.7
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

2284.8

Cash from operations

3638.9

Cash from investing

-724.6

Cash from financing

-2547.7

Net change in cash

21.6

Free cash flow

4492.9
Consolidated Cash Flow

Particulars

Mar 24 (₹ value in crores)

1495.4

Cash from operations

3233.6

Cash from investing

-1012.3

Cash from financing

-1528.2

Net change in cash

391.0

Free cash flow

4137.7

(Values in Cr)

Net income

Net change

Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

4239.8

Cash from operations

2896.8

Cash from investing

-1830.6

Cash from financing

-300.8

Net change in cash

-132.3

Free cash flow

3481.0
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

2032.2

Cash from operations

1471.4

Cash from investing

-1959.3

Cash from financing

827.0

Net change in cash

-54.1

Free cash flow

2221.5
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

1163.9

Cash from operations

1542.2

Cash from investing

586.2

Cash from financing

-1709.8

Net change in cash

148.6

Free cash flow

2084.0
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

1688.5

Cash from operations

2491.0

Cash from investing

-2713.8

Cash from financing

255.3

Net change in cash

-231.3

Free cash flow

3019.6
Standalone Cash Flow

Particulars

Mar 24 (₹ value in crores)

1625.9

Cash from operations

1381.8

Cash from investing

55.0

Cash from financing

-966.7

Net change in cash

268.9

Free cash flow

1978.69

Financials

<p>Months listed along the bottom of the graph represent a financial year.</p> <p> </p> <p><b>Consolidated</b>: Data of the entire group of companies.</p> <p><b>Standalone</b>: Data of a single company.<br /> </p>

Company name

Price

P/E

P/B

Market cap

52 week low/high

38.3

20.59

2.09

293.51

34.11 / 77.7

121.35

15.17

1.21

1278.67

92.25 / 184.95

1482.05

22.7

3.83

119696.35

1310.05 / 1702.0

294.0

24.36

2.98

865.27

145.0 / 449.0

₹38.3

23.07

6.51

293.51

34.11 / 77.7

₹712.85

40.55

6.3

2060.89

548.05 / 861.4

₹7944.65

118.49

29.23

19861.63

5415.55 / 9199.0

₹121.35

18.53

1.2

1278.67

92.25 / 184.95

Zydus Lifesciences Ltd technical summary

909.452.22
4
12
Bullish
894.2
893.1
892.0
888.4
887.3
892.4
916.6
938.6
898.3
893.4
891.7
887.5
879.0
885.0
918.8
989.6
883.77
PIVOT
First support871.53
Second support853.42
Third support₹841.18
RSI50.86
MACD4.7%
Commodity Channel Index (CCI)₹-13.36
First resistance901.88
Second resistance914.12
Third resistance-932.23
ADX10.89
Williams % R-49.75
Date2025-05-21
Same day492444
Week506984
Month522813
1 year
-18.25
3 years
34.88
Price change analysis
--1.53%
Over 1 month
-5.24%
Over 3 month
-0.48%
Over 6 month
--5.76%
Over 3 year
34.88%
Over 6 year
20.9%

Zydus Lifesciences Ltd shareholding pattern

Holding %

Public

6.68%

Promoter holdings

74.99%

FII

7.31%

DII

11%

Promoter shares

0%

Promoter shares

Zydus Family Trust (pankaj R. Patel, Pritiben P. Patel And Sharvil P. Patel-trustees)

Life Insurance Corporation Of India

Icici Prudential Bluechip Fund

Kotak Flexicap Fund

Parag Parikh Flexi Cap Fund

Arati Rajiv Mehta

Taraben Patel Family Will Trust (mr.pankaj R Patel And Dr. Sharvil P Patel-trustees)

Pripan Investment Private Limited

Ritaben Yatinbhai Desai

Jasodaben Babubhai Patel

Ayushi Rajiv Mehta Jointly With Arati Rajiv Mehta

Shivani Pankajbhai Patel

Sharvil Pankajbhai Patel

Pritiben Pankajbhai Patel

Pankaj Ramanbhai Patel Huf (pankaj Ramanbhai Patel-karta)

Pankaj Ramanbhai Patel

Share

Category

754313343
(74.96)%

Shareholding of Promoter and Promoter Group

38714308
(3.85)%

Public Shareholding

17738978
(1.76)%

Public Shareholding

14071531
(1.4)%

Public Shareholding

13491854
(1.34)%

Public Shareholding

76087
(0.01)%

Shareholding of Promoter and Promoter Group

14775
(0)%

Shareholding of Promoter and Promoter Group

17730
(0)%

Shareholding of Promoter and Promoter Group

24874
(0)%

Shareholding of Promoter and Promoter Group

41577
(0)%

Shareholding of Promoter and Promoter Group

17727
(0)%

Shareholding of Promoter and Promoter Group

14775
(0)%

Shareholding of Promoter and Promoter Group

14775
(0)%

Shareholding of Promoter and Promoter Group

14775
(0)%

Shareholding of Promoter and Promoter Group

29550
(0)%

Shareholding of Promoter and Promoter Group

44326
(0)%

Shareholding of Promoter and Promoter Group

About Zydus Lifesciences Ltd

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain including innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), Active Pharmaceutical Ingredients (APIs), animal healthcare products and consumer wellness products. The Company operate manufacturing facilities at Ahmedabad, Ankleshwar and Vadodara in Gujarat, Ponda in Goa, Raigad in Maharashtra and Solan in Himachal Pradesh. Founded by the Late Promoter, Mr. Ramanbhai B. Patel, the Company was incorporated in May, 1995 and converted into a Public Limited Company in July, 1996. The Company's operation includes pharmaceuticals, which includes human formulations, veterinary formulations and bulk durgs, diagnostics, herbal products, skin care products and OTC products. In the year 1996, the Company made a strategic alliance with Gulin Pharma of China and launched Falcigo in India, which is an anti-malarial segment. In May 2000, the company acquired formulation business of Recon Ltd, which strengthens the company in the southern market. In the year 2001, they acquired German Remedies which was the largest M&A in the Indian Pharmaceutical sector and in the same year, they entered into a joint venture with US based Onconova for collaborative research in the field of Oncogenomics. In April 2002, the Company acquired Banyan Chemicals, a Vadodara based company with the US FDA approved plant. In the year 2003, German Remedies, Recon Healthcare, Zoom Properties and Zydus Pathline merged with the company. Also, they acquired Alpharma France, which spearheaded the group operations in France. In the same year, the company emerged as a 'Partner of Choice' for Schering AG to manufacture and market the products in India. In November 2004, the Company entered into a strategic alliance with Zambon Group in Italy to open up new avenues in contract manufacturing. In the same year, it signed a long term strategic pact with Boehringer Ingelheim India Ltd, a wholly owned subsidiary of Boerhringer Ingelheim (BI) to manufacture and market BI's products in India. In the year 2005, the Company entered into a strategic alliance with Mallinckrodt Pharmaceuticals Generics, a business unit of Tyco Healthcare to market the product manufactured by the company under a joint label. In the same year, the company signed a 50:50 joint venture with Mayne Pharma of Australia to manufacture generic injectable, cytotoxic (anti-cancer) medicines as well as active pharmacetical ingredients (API) for global markets. During the year 2005-06, the Company signed a 50:50 joint venture with one of India's top biotech companies Bharat Serums and Vaccines Ltd (BSV) and formed Zydus BSV Pharma Pvt Ltd to develop, manufacture and market non-infringing and proprietary Novel Drug Delivery System (NDDS) of an approved anti-cancer product for global markets. During the year 2006-07, the company entered into share purchase agreement to acquire 97.95% stake in Liva Healthcare Ltd, which is carrying on business of manufacturing and marketing of Formulations. They established a green field facility for Solid Oral Dosage Forms in Sikkim mainly for domestic market. They also installed Lyophilisation facility at Moraiya plant with annual capacity of 7.5 million dosages to cater to both Indian and International markets. During the year 2007-08, the company restructured their formulation division namely Alidac and launched two new sub division namely Corza and Fortiza. Also, they forayed into the neutraceutical industry and launched a new division, Zydus Nutriva. The upgradation of the injectibles facility at Moraiya was completed and also, they expanded their manufacturing facility at Ankleshwar. Zydus Healthcare Brasil Ltd, Brazil, a wholly owned subsidiary of the company, acquired 100% shareholding of Quimica e Farmaceutica Nikkho Do Brasil Ltda, a Brazilian Pharmaceutical company, to expand their branded business in Brazil. Also, Zydus Pharmaceuticals Inc, Japan, a wholly owned subsidiary of the company, acquired 100% shareholding in Nippon Universal Pharmaceuticals Co Ltd, Japanese Company, which is carrying out business of manufacturing and marketing of pharmaceutical products in Japan. In February 2008, the company and Karo Bio of Sweden made a three year strategic collaboration in the area of drug discovery and development. In May 2008, the company entered into Spain with the acquisition of 100% stake in Laboratories Combix. In June 2008, the company through their wholly owned subsidiary, Zydus Healthcare SA Pty Ltd is acquiring majority state of 70% in Simayla Pharmaceuticals of South Africa. The company decided to demerge the Consumer Products Division of the company and transferred to Carnation Nutra Analogue Foods Ltd, which is a subsidiary of Cadila Healthcare and the merger of Zydus Hospital and Medical Research Pvt Ltd with the company. In August 2008, the company entered into an agreement with WHO to explore a possible collaboration in the development of a cocktail for the treatment of rabies, through the use of monoclonal antibodies. The Board of Directors of Cadila Healthcare and Carnation Nutra-Analogue Foods Ltd. at their respective meeting held on 4 July 2008 approved the modalities of the composite scheme of arrangement for restructuring of the consumer products division of Cadila Healthcare. The board approved the demerger of the consumer products division of Cadila Healthcare into Carnation, which is a subsidiary of Cadila Healthcare and the merger of Zydus Hospital and Medical Research Pvt. Ltd. (ZHMRPL) with Cadila Healthcare. As consideration, Carnation will allot to the shareholders of Cadila Healthcare 4 fully paid-up equity shares of Rs 10 each for every 15 equity shares of Rs 5 each held in Cadila Healthcare. On 28 January 2011, Cadila Healthcare and Bayer HealthCare announced that they have signed an agreement to set up the Joint Venture Company Bayer Zydus Pharma for the sales and marketing of pharmaceutical products in India. Each party will hold 50 percent of the shares of Bayer Zydus Pharma, headquartered in Mumbai, and be equally represented on its management board. Bayer Zydus Pharma will start operations with Bayer HealthCare's Pharmaceutical Division contributing its existing sales and marketing business in India to the new company and Cadila Healthcare contributing its women's healthcare products, diagnostic imaging business and other products. Bayer Zydus Pharma will operate in key segments of the Indian pharmaceuticals market with a focus on women's healthcare, metabolic disorders, diagnostic imaging, cardiovascular diseases, anti-diabetic treatments and oncology. On 17 June 2011, Cadila Healthcare announced that Zydus Pharmaceuticals USA Inc., through its subsidiary Zynesher Pharmaceuticals USA LLC has entered into an agreement to acquire the assets of the US based pharmaceutical company Nesher Pharmaceuticals Inc. Nesher operates as the generic subsidiary of KV Pharmaceutical, based at St. Louis, Missouri, USA. The financial details of the agreement were not disclosed. Nesher has considerable expertise in niche therapies which have development or production barriers, such as controlled release medications or DEA-controlled substances. The broad-based assets purchase agreement includes assets and assumption of certain liabilities, Nesher's existing and pipeline ANDAs, certain manufacturing facilities and a full fledged research and development lab. With this, Zydus will now be able to manufacture and distribute generic controlled substances in the US market, which otherwise cannot be imported. On 1 April 2011, Cadila Healthcare announced that it has ended the financial year 2010-11 on a high note, taking its revenues beyond the $1 billion mark. On 27th July 2011, Cadila Healthcare announced that its 100% subsidiary Zydus Animal Health Limited (AHL) has signed a Share Purchase Agreement with ICICI Venture, to acquire 100% shareholding of Finest Procuring Solutions Limited, which in turn holds 100% shareholding of Bremer Pharma GmbH, of Germany. The agreement includes the transfer of all key assets, people, brands and export contracts of Bremer - a global animal health company headquartered in Warburg-Scherfede, Germany. The acquisition will help Zydus AHL expand its animal health business and gain strategic access to the key markets across Europe, South America, Asia and Africa. On 21 December 2011, Cadila Healthcare announced the acquisition of 100% stake in Biochem, one of the top 40 pharma companies in India. A privately-held company headquartered in Mumbai, Biochem is a well-integrated pharma player with a presence in the antibiotics, cardiovascular, anti-diabetic and oncological segments. Biochem has reported sales of Rs 264.5 crore for the year 2010-2011. On 18 July 2012, Zydus Urosciences, the specialty division of Cadila Healthcare, announced the launch of Udenafil, a next generation therapy for erectile dysfunction, for the first time in India. The group has an exclusive license to market this patented molecule developed by Dong-A Pharmaceuticals of Korea, in India. On 25 July 2013, Cadila Healthcare and IDRI, a Seattle-based non-profit research and product development organization, announced that they are collaborating on the production and clinical development of IDRI's visceral leishmaniasis (VL) vaccine candidate, designed to prevent the deadly parasitic disease. Known as Kala-Azar in India, VL is transmitted by the bite of an infected sand fly. Cadila Healthcare and IDRI will collaborate to conduct clinical development activities in India with the goal of developing, registering and marketing this vaccine candidate for the prevention of VL, which will achieve the objective of global access - that is, ensuring the vaccine is affordable to and accessible by all people in need. Conducting trials in India, where there are real-life situations of disease exposure, is critical to determining the effectiveness of IDRI's VL vaccine candidate and ensuring it is approved and available within endemic countries. On 16 October 2013, Cadila Healthcare and Pieris AG, a next generation therapeutic protein R&D company, announced that they have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The collaboration combines Pieris' drug discovery and early development capabilities with Cadila's expertise in biologics development, regulatory affairs and biologics manufacturing. Under the terms of the agreement, Cadila Healthcare will take the lead in advancing Anticalin drug candidates through formal preclinical development and into clinical development, undertaking drug development in accordance with ICH guidelines. Cadila Healthcare has been granted exclusive marketing rights in India and several other emerging markets, while Pieris retains exclusive marketing rights in key developed markets. On 15 September 2014, Cadila Healthcare and Gilead Sciences, Inc. announced that they have signed a non-exclusive licensing agreement which will allow the generic manufacture of sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir for distribution in 90 developing countries, including India. Under the licensing agreement, Cadila Healthcare will receive a complete technology transfer of the Gilead manufacturing process to enabling production to be scaled up as quickly as possible. Zydus will set its own prices for the generic product, paying a royalty on sales to Gilead to support product registrations, medical education and training, safety monitoring and other business essential activities. The licenses also permit the manufacture of sofosbuvir or ledipasvir in combination with other chronic hepatitis C medicines. On 9 December 2014, Cadila Healthcare announced that it has become the first company in the world to launch the biosimilar of Adalimumab - the world's largest selling therapy. Developed by the researchers at the Zydus Research Centre, the biosimilar has been approved by the Drug Controller General of India and will be marketed under the brand name, Exemptia to treat auto immune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing Spondylitis. On 17 March 2015, Cadila Healthcare announced the launch of SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences, Inc. SoviHep will provide succour to more than 10 million patients who suffer from Hepatitis C in India. The therapy will be marketed by the specialty division of the group, Zydus Heptiza. Zydus and Gilead Sciences, Inc. had signed a non-exclusive licensing agreement which will allow the manufacture of sofosbuvir and the fixed-dose combination of ledipasvir/sofosbuvir for distribution in 91 countries including India. On 31 December 2015, Cadila Healthcare announced that the company has received a warning letter by the USFDA relating to its Moraiya formulation facility and Ahmedabad API facility (Zyfine). In a statement, Cadila Healthcare said that the company is working hard to ensure that the commitments made to the USFDA are fully completed. The company will continue to take all necessary steps to ensure that the USFDA is fully satisfied with the company's remediation measures for these two manufacturing facilities. There are no products in the US market which use API of Zyfine facility. On 5 January 2016, Cadila Healthcare announced the strategic acquisition of select brands and the manufacturing operations in Haridwar, India, of Zoetis, a global animal health company. The acquisition will help Cadila Healthcare expand its animal health business in India and gain access to manufacturing operations which have also been catering to global markets. The financial details of the deal were not disclosed. As a result of this acquisition, Cadila gains access to a wide range of nutrition as well as therapeutic products which have strong brand equity and a combined turnover of Rs 171 crore. A major boost to the company's portfolio would be the addition of livestock farmcare products which are well accepted in the market. An access to the WHO GMP approved manufacturing facility is expected to boost Cadila's exports and institutional business. The plant spread over 10,000 sq. metres manufactures Tablets, Liquid Orals and Injectables. On 19 February 2016, Cadila Healthcare announced that it has received approval from the USFDA to market Doxycycline Capsules USP, 50 mg, 75 mg, and 100 mg. The drug falls in the anti-bacterials segment. With this first approval, the group will now commence supplies to the US market from its formulation manufacturing facility located at the SEZ in Ahmedabad. On 28 March 2016, Cadila Healthcare announced that its wholly owned subsidiary Zydus Healthcare Limited has entered into a definitive agreement to acquire Actibile' from Albert David Limited (ADL). The brand falls in the gastroenterology segment and is used for dissolving gall bladder stones. The deal will be financed through internal accruals. On 15 June 2016, Cadila Healthcare announced that it has signed a strategic collaboration agreement with Eczacibasi Ila Pazarlama A.S. a leading healthcare company of Turkey, to market biotech products in the Turkish market. The agreement involves the import of biosimilars which are currently unavailable in the country especially for the treatment of cancer and also paves the way for a long term strategic collaboration to produce and launch new products in the market. On 20 June 2016, Cadila Healthcare announced that it has strengthened its US portfolio with the acquisition of two ANDAs from Teva that are being divested by Teva as a pre-condition to its acquisition of Allergan's generic business. The acquisition of these ANDAs is contingent on the closing of the Teva-Allergan Generics transaction and approval by the US Federal Trade Commission. The financial details of the transaction were not disclosed. These ANDAs have been acquired by its 100% subsidiary, Zydus Worldwide DMCC and the transaction will be financed through internal accruals. The acquired portfolio comprises an ANDA which is already commercialised and one pipeline ANDA which is a transdermal patch. The estimated market size of the two ANDAs put together is nearly US$ 200 million. On 7 July 2016, Cadila Healthcare announced that it has signed a non-exclusive, royalty free agreement with The Medicines Patent Pool (MPP) for the generic production of Bristol-Myers Squibb's daclatasvir, a novel direct-acting antiviral (DAA) that is proven to help cure multiple genotypes of the Hepatitis C Virus (HCV). The agreement sub-licences Cadila to produce and sell daclatasvir in 112 low and middle income countries. The MPP licence allows generic manufacturers to develop fixed-dose combinations that offer the potential to treat all of the six major genotypes of HCV. On 20 September 2016, Cadila Healthcare and Takeda Pharmaceutical Company Limited announced a partnership to tackle chikungunya, an emerging infectious disease. The chikungunya virus is most often spread to people by Aedes aegypti and Aedes albopictus mosquitoes, the same vectors that spread dengue and zika. The broad-based agreement includes early stage development to the final commercialisation of the vaccine. There is currently no vaccine to prevent or medicine to treat chikungunya virus infection. On 30 September 2016, Cadila Healthcare and Medicines for Malaria Venture (MMV) announced a collaboration to develop the investigational antimalarial compound MMV674253. Cadila Healthcare will lead the development of the novel compound and MMV will provide support including scientific expertise and access to tools in the field of malaria drug development and delivery. The aim of the collaboration is to provide an effective alternative to the current front-line antimalarial drugs for the treatment of uncomplicated P. falciparum malaria, artemisinin-based combination therapies (ACTs), which are under threat of resistance. On 28 December 2016, Cadila Healthcare announced that its wholly owned subsidiary company Zydus Healthcare Limited (Zydus) has acquired six brands from MSD and its subsidiaries. The brands are DECA-DURABOLIN, DURABOLIN, SUSTANON, MULTILOAD, SICASTAT and AXETEN range, which fall in the men's health, women's health, wound management and cardiovascular therapy segments, respectively. The deal includes transfer of distribution and commercialization rights and assignment of trademarks of all the six brands to Zydus Healthcare Limited in India. As a part of the deal, Organon (India) Private Limited, one of the legal subsidiaries through which MSD operates its business in India, has also transferred the distribution and commercialization rights for DECA-DURABOLIN and DURABOLIN to Zydus for Nepal. Financial details of the deal were not disclosed. The strategic brands' acquisition will strengthen Cadila's portfolio in key therapeutic segments. The acquired portfolio had clocked sales of Rs 84 crore in 2015. On 19 January 2017, Cadila Healthcare announced that it has acquired Sentynl Therapeutics Inc., a US based specialty pharma company specialized in marketing of products in the pain management segment. The transaction will be EPS accretive. With this acquisition, Cadila Healthcare makes a foray into the specialty pain market in the US valued at $8 billion. It gains access to the specialty distribution network and a large prescriber base. Sentynl provides healthcare professionals with treatment solutions that enable them to meet the needs of individual patients. This acquisition will also enable Cadila Healthcare to leverage its existing assets in the US. The acquisition was solely funded by Bank of Tokyo-Mitsubishi UFJ. On 23 February 2017, Cadila Healthcare announced that the USFDA has approved the group's plans to initiate a Phase 2 clinical trial of Saroglitazar Magnesium (Mg) in patients with Primary Biliary Cholangitis (PBC) of the liver. This randomized, double-blind Phase 2 trial will evaluate Saroglitazar Magnesium 2mg and 4 mg Vs. Placebo. PBC is a liver disease caused due to progressive destruction of the bile ducts in the liver which leads to reduction of bile flow - a condition referred to as cholestasis. On 24 February 2017, Cadila Healthcare announced that it has received approvals from the Drug Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO) and the Central Drug Laboratory (CDL) to market the Tetravalent Inactivated Influenza vaccine for seasonal flu, VaxiFlu - 4. With this, Cadila will become the first Indian pharma company and second in the world to launch a Tetravalent Inactivated Influenza vaccine. The vaccine provides protection from the four influenza viruses- H1N1, H3N2, Type B (Brisbane) and Type B (Phuket). VaxiFlu - 4 will be marketed by Zydus Vaxxicare - a division of the group focussing on preventives. On 21 June 2017, Cadila Healthcare announced that its formulations manufacturing facility at Moraiya, Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA signifying the successful closure of the audit. The Moraiya manufacturing plant had completed the USFDA audit from 6 February to 15 February 2017 with zero 483 observations. Post the audit, the plant has received several product approvals, including the final approval to market Mesalamine Delayed- Release Tablets USP, 1.2 g in the US. On 5 July 2017, Cadila Healthcare announced the initiation of a phase II trial investigating ZYAN1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated with Chronic Kidney Disease (CKD). ZYAN1 is an oral small molecule that has been designed to inhibit hypoxia-inducible factor prolyl hydroxylase, and thereby increase the natural production of hemoglobin and RBCs in anemic patients. ZYAN1 has been shown to improve iron mobilization and has the potential to reduce or eliminate the need for iron supplementation. On 5 July 2017, Cadila Healthcare and Phibro Animal Health Corporation announced their intention to enter into a long-term arrangement to license Phibro's innovative poultry vaccine technologies and know-how to a new vaccine manufacturing facility to be built by Cadila to serve the fast growing poultry market in India. The availability of new advanced poultry vaccines, which were until now being imported into India, adds a new dimension to the Make-in-India movement in the animal health segment. On 12 July 2017, Cadila Healthcare announced its succession planning move with the appointment of Dr. Sharvil Patel as the managing director of the company. While Mr. Pankaj Patel will continue as the Chairman of the company, he has stepped down as the Managing Director. On 29 August 2017, Cadila Healthcare announced that its formulations manufacturing facility at Pharma SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA signifying the successful closure of the audit. The manufacturing plant had completed the USFDA audit from 16 to 24 January 2017. On 7 September 2017, Cadila Healthcare announced that the USFDA inspected its Moraiya facility from 31 August 2017 to 7 September 2017. At the end of the inspection, no observation (483) was issued. On 19 September 2017, Cadila Healthcare announced that it has entered into an exclusive agreement for the technology know-how for varicella vaccine production in the Russian Federation with Pharm Aid Ltd., headquartered in Russia. The exclusive agreement was signed at the BIOTECHMED conference in Gelendzhik, Russia. Pharm Aid Ltd, has been set up by Nacimbio together with Ishvan Pharmaceuticals Ltd., for the localization of innovative vaccine production in Russia. Through this agreement, Cadila Healthcare gains access to the public and private market segments in the Russian Federation, Belarus, Uzbekistan, Kazakhstan, Armenia and Kyrgyzstan. On 29 November 2017, Cadila Healthcare announced that the company has entered into a public private partnership with the Indian Council of Medical Research (ICMR) to launch new diagnostic kits, developed by ICMR's National Institute of Virology (NIV), Pune to detect neglected infectious diseases in livestock. The kits have been developed to detect infections in the animal population, as they often are the hosts or reservoirs, spreading the infection to humans who come in close contact with them. On 9 February 2018, Cadila Healthcare announced that the USFDA inspected its Moraiya facility from 5 February to 9 February, 2018. At the end of the inspection, no observation (483) was issued. On 8 March 2018, Cadila Healthcare announced that it has entered into a definitive agreement with Medicure International Inc., a subsidiary of Medicure Inc. (Medicure) to commercialize its 505(b)(2) New Drug Application (NDA) product, pitavastatin magnesium (ZYPITAMAGTM) in the United States. The launch of ZYPITAMAG, which is used to manage cholesterol levels, marks the first branded product launch for the company in the US. Medicure is a US pharmaceutical company and has a proven track-record of successful commercialization of products in the therapeutic segments of cardiovascular and metabolic diseases. As a part of this agreement, Cadila Healthcare will hold the NDA and Medicure will be responsible for the sales and marketing of ZYPITAMAG. On 28 March 2018, Cadila Healthcare announced that the USFDA inspected its Topical manufacturing facility located at Changodar, Ahmedabad from 22 March to 28 March 2018. At the end of the inspection, no observation (483) was issued. During the year 2021, Zydus Discovery DMCC (ZDD), a subsidiary of the Company completed Phase II clinical trials of Saroglitazar Magnesium for Primary Biliary Cholangitis (PBC) indication. USFDA granted the Orphan Drug Designation (ODD) and Fast Track Designation to Saroglitazar Magnesium in the treatment of patients with Primary Biliary Cholangitis (PBC). The Company launched its first biosimilar viz. Pegfilgrastim in Russia. It launched 30 new products in the US generics market. It commenced commercial manufacturing from 2 more areas of Oral Solid Dosage formulations manufacturing facility located in Ahmedabad SEZ. The Company improved the capacity of Goa formulations facility by 25% by de-bottlenecking granulation area through improvement in cycle time of key products. In year 2022, Zydus Animal Health and Investments Limited (ZAHL), a wholly owned subsidiary of the Company disposed / sold of its Animal Healthcare Established Markets Undertaking to Zenex Animal Health India Private Limited (Purchaser), through slump sale, at a consideration csoting Rs. 29,210 million, which got completed in July, 2021. A molecule was launched in India in March, 2022 under the brand name, 'Oxemia'. It launched Ujvira, (Trastuzumab Emtansine biosimilar) in India, which is the first biosimilar of an Antibody Drug Conjugate (ADC) Kadcyla and a highly effective drug for treating both early and advanced HER2 positive breast cancer. It received a tentative approval from the USFDA for a New Drug Application (NDA) for Sitagliptin base tablets. During the year, 2022 Sentynl entered into an asset purchase agreement with BridgeBio Pharma for acquisition of NULIBRY (Fosdenopterin) for Injection to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultrarare, life-threatening paediatric genetic disorder. During 2023, the Company got into a Business Transfer Agreement for purchase of the business undertakings of Watson Pharma Private Limited through slump sale on a going concern basis costing Rs 46.8 Crores. In 2023-24, the Company launched new products in the US generics market, including Lenalidomide Capsules (gRevlimid) and Topiramate Extended Release Capsules (gTrokendi). The Company was the first player to launch the generic version of Topiramate Extended Release Capsules.

Parent Organisation

Cadila

NSE Symbol

ZYDUSLIFE

Founded

1995

View more stocks

THEMIS MEDICARE LTD.

₹170.74

12.99%

ALEMBIC PHARMA LTD

₹1028.65

12.67%

ANUH PHARMA LIMITED

₹203.4

12.57%

SYNCOM FORMU (I) LTD

₹18.93

8.23%

CAPLIN POINT LAB LTD.

₹2161.1

7.51%

AARTI PHARMALABS LIMITED

₹855.25

7.37%

AMI ORGANICS LIMITED

₹1188.9

5.81%

AARTI DRUGS LTD.

₹480.6

5.63%

MOREPEN LAB. LTD

₹63.67

5.1%

MARKSANS PHARMA LIMITED

₹253.51

5.01%

Popular stocks

Rail Vikas Nigam
Suzlon Energy
NHPC
Yes Bank
TATA Motors
BHEL
HDFC Bank
State Bank of India
TATA Power
TATA Steel
NBCC India
Infosys India
Adani Power
IFCI
Coal India
OLA Electric

What’s trending

Top gainers Top losers 52-week high 52-week low All stocks

All stocks

DYNAMIND

DYNAMIC INDUSTRIES LTD.

120.37

+20.06 +20%

ADDIND

ADDI INDUSTRIES LTD.

80.64

+13.44 +20%

NAHARPOLY

NAHAR POLYFILMS LTD.

262

+41.35 +18.74%

NAHARPOLY

NAHAR POLY FILMS LIMITED

261.99

+40.61 +18.34%

View all

Top gainers

INDUSINDBK

INDUSIND BANK LIMITED

793.9

+23.95 +3.11%

TATASTEEL

TATA STEEL LIMITED

162.69

+1.05 +0.65%

JIOFIN

JIO FIN SERVICES LTD

275.8

+1.45 +0.53%

BHARTIARTL

BHARTI AIRTEL LIMITED

1831.5

+9.00 +0.49%

View all

Top losers

POWERGRID

POWER GRID CORP. LTD.

289.3

-6.85 -2.31%

TRENT

TRENT LTD

5348

-95.50 -1.75%

ITC

ITC LTD

425.5

-7.50 -1.73%

RELIANCE

RELIANCE INDUSTRIES LTD

1406.3

-22.90 -1.60%

View all

Frequently asked questions

What is share price of ZYDUS LIFESCIENCES LTD?
<p> As of May 22 2025 03:29 PM, at May 22 2025 03:29 PM, the ZYDUS LIFESCIENCES LTD share price stands at Rs.904.0.</p>
What is the market cap of ZYDUS LIFESCIENCES LTD?
<p>As of May 22 2025 03:29 PM, the market cap of ZYDUS LIFESCIENCES LTD stands at Rs.90963.55 Cr. <br /> </p>
What is the PE and PB ratio of ZYDUS LIFESCIENCES LTD?
<p> The PE and PB ratios of ZYDUS LIFESCIENCES LTD is 15.5 ratio and 210.58 ratio as of May 22 2025 03:29 PM.</p>
What is the 52 week high and low of ZYDUS LIFESCIENCES LTD?
<p>The 52 week high and low of ZYDUS LIFESCIENCES LTD is Rs.1324.3 and Rs.795.0 as of May 22 2025 03:29 PM.<br /> </p>
How can I buy ZYDUS LIFESCIENCES LTD share?
<p>You can easily buy&nbsp;ZYDUS LIFESCIENCES LTD shares on&nbsp;the <b>Bajaj Broking</b> platform by opening a Demat account&nbsp;and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.<br> </p>
Show More Text Show Less Text

Related articles

Article 1

How to Buy Shares

Jan 30, 2025

Read More

share-market-timings-in-india 2

Share Market Timings in India

May 15, 2023

Read More

what-is-trading 3

What is Trading

Mar 25, 2025

Read More

what-is-demat-account 4

What is Demat Account: Meaning, Types & Benefits

May 25, 2021

Read More


Related videos

Features and benefits of Demat Account
 
 

Features and benefits of Demat Account

How to open a Demat and Trading account with us
 
 

How to open a Demat and Trading account with us

Stock market basics for beginners
 
 

Stock market basics for beginners

Features and Benefits of a Trading account
 
 

Features and Benefits of a Trading account

Different types of Demat accounts
 
 

Different types of Demat accounts


Related tags

Top gainers
Top losers
52 week high
52 week low
All stocks

You are here

  1. Home
  2. Investments
  3. Zydus Lifesciences Ltd Share Price

Related links

  • Investments
  • Brokerage calculator
  • Demat account
  • Trading account

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."
 

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines. Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.


Powered by Bajaj Financial Securities Limited (Bajaj Broking)

Go To Top

Application Forms

  • Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • Insta EMI Card
  • Wallet Care
  • Health Insurance
  • Loan for Doctors
  • Fixed Deposit
  • Loan Against Property
  • Loan for Chartered Accountants
  • Open Demat Account
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Mutual Fund
  • Secured Business Loan
  • Loan for Lawyer

Products Portfolio

Loans

  • Personal Loan
  • Insta Personal Loan
  • Business Loan
  • Home Loan
  • Gold Loan
  • MSME Loan
  • Mortgage Loan
  • Loan Against Property
  • Two & Three Wheeler Loan
  • Education Loan on Property
  • Personal Loan for Self-employed Individuals
  • Two-wheeler Loan
  • New Car Finance
  • Used Car Loan
  • Loan Against Car
  • Car Loan Balance Transfer and Top-up
  • Used Cars and Loan

Insurance

  • Health Insurance
  • Car Insurance
  • Pocket Insurance
  • Investment Plans
  • Appliances Extended Warranty
  • Pocket Subscription

Finance for Professionals

  • Loan for Doctors
  • Loan for Chartered Accountants

Investments

  • Fixed Deposit
  • Open Demat Account
  • Mutual Funds
  • NFO (New Fund Offer)
  • ELSS Mutual Funds
  • Equity Mutual Funds
  • Hybrid Mutual Funds
  • Debt Mutual Funds
  • Multi Cap Mutual Funds
  • Large Cap Mutual Funds
  • Mid Cap Mutual Funds
  • Small Cap Mutual Funds
  • Liquid Mutual Funds
  • Aggressive Hybrid Mutual Funds

Pocket Subscription

  • Mobile Protection Plan
  • Wallet Care
  • Fonesafe Lite
  • Neuro Care Plan
  • Health Prime Max
  • Cpp Road Assist
  • Healthy Body Package

Bajaj Mall

  • Smartphones
  • Mattress
  • Smartwatches
  • Cycles
  • Music & Audio
  • Speakers
  • Water Purifiers
  • Laptops
  • Two-wheeler
  • Washing Machine
  • Televisions
  • Air Conditioner
  • Refrigerators
  • Furniture

Services

  • Sign-in to our Customer Portal (My Account)
  • Manage your Profile
  • Manage your Mandate
  • Manage your Loans
  • Manage your Flexi Loans
  • Manage your Insta EMI card
  • Manage your Fixed Deposit

Wallets & Cards

  • Wallet
  • Bajaj Finserv Insta EMI Card

Value Added Services

  • Credit Pass
  • Gold Rate

Payments

  • All Payments
  • Wallet
  • UPI
  • Mobile recharge
  • Electricity Bill Payment
  • DTH Recharge
  • Loan Repayment
  • Gas Booking
  • Rewards
  • Bajaj Pay FASTAg
  • Bajaj Pay Wallet KYC Upgrade
  • Bajaj Pay FASTAg Registration
  • Bajaj Pay FASTag Replacement
  • Bajaj Pay FASTag Closure
Pre-approved Offers
Offers & Promotions
Article and Insights

Calculators

  • Personal Loan EMI Calculator
  • Home Loan EMI Calculator
  • Home Loan Eligibility Calculator
  • Business Loan EMI Calculator
  • Personal Loan Eligibility Calculator
  • Loan Against Property EMI Calculator
  • Education Loan on Property Calculator
  • FD Calculator
  • Gratuity Calculator
  • Income Tax Calculator
  • Top-up Loan Calculator
  • Part-prepayment Calculator
  • GST Calculator
  • Gold Loan Calculator
  • EMI Calculator
  • Used Car Loan EMI Calculator
  • Interest Calculator
  • SIP Calculator
  • Credit Score Simulator
  • Flexi Day Wise Interest Calculator
  • Flexi Transaction Calculator
  • Secured Business Loan EMI Calculator
  • Secured Business Loan Eligibility Calculator
  • Lumpsum Calculator
  • Step Up SIP Calculator
  • BMI Calculator
  • IDV Calculator
  • Commercial Loan EMI Calculator
  • Medical Equipment Finance EMI Calculator
  • Term Loan Calculator
  • Equipment Machinery Loan EMI Calculator
  • Doctor Loan EMI Calculator
  • Doctor Loan Eligibility Calculator
  • Chartered Accountant Loan EMI Calculator
  • Simple Interest Calculator
  • Compound Interest Calculator
  • Brokerage Calculator
  • Mutual Fund Calculator
  • Two wheeler Loan EMI Calculator
  • New Car Loan EMI Calculator

Legal

  • Moratorium Policy (Covid-19)
  • Moratorium Policy March 2020
  • Information Security Practices
  • Information Security Measures
  • Citizens Charter
  • Privacy Policy
  • Phishing
  • Disclaimer
  • Forms Centre
  • Fees & Charges
  • Fair Practices Code
  • Interest Rate Policy
  • Disclosures
  • Cautionary Notice
  • Whistle Blower Policy
  • Confidential Feedback
  • Resolution Plan 2.0
  • Terms & Conditions
  • Resolution Plan 2.0 FAQs
  • Ombudsman Scheme
  • SMA/NPA Account Classification
  • Terms of Use
  • Sachet
  • Handover of Property Documents
  • Notices
  • Policy on Fees & Charges
  • BFL - Floating Reference Rates

Reach Us

  • Contact us
  • Raise A Request
  • Frequently Asked Questions
  • Make Online Payment
  • Branch Locator
  • Our Partners
  • Galaxy - Partner portal
  • Bajaj Finserv for Business
  • Call Us

Corporate Office

6th Floor Bajaj Finserv Corporate Office, Off Pune-Ahmednagar Road, Viman Nagar, Pune - 411014

Bajaj Finance Limited Regd. Office

Akurdi, Pune - 411035
Ph No.: 020 7157-6403
Email ID: investor.service@bajajfinserv.in

Corporate Identity Number (CIN)

L65910MH1987PLC042961

IRDAI Corporate Agency (Composite) Regn No.

CA0101
(Valid till 31-Mar-2028)

URN - WEB/BFL/23-24/1/V1

Bajaj Finserv Limited Regd. Office

Bajaj Auto Limited Complex Mumbai - Pune Road,
Pune - 411035 MH (IN)
Ph No.: 020 7157-6064
Email ID: investors@bajajfinserv.in

Corporate Identity Number (CIN)

L65923PN2007PLC130075

Our Companies

  • Bajaj Finserv Ltd.
  • Bajaj Finance Ltd.
  • Bajaj Allianz General Insurance
  • Bajaj Allianz Life Insurance
  • Bajaj Markets
  • Bajaj Housing Finance Ltd.
  • Bajaj Broking
  • Bajaj Finserv Health Ltd.
  • Bajaj Finserv Asset Management Ltd.
Company Name
Download App

© Bajaj Finserv 2007-2025. All rights reserved.